cilostazol has been researched along with Blood Poisoning in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Whether cilostazol (6-[4-(1-cyclohexyl-1H-tetrazol-5-yl) butoxy]-3,4-dihydro-2-(1H)-quinolinone), anticoagulant, protects mice against sepsis and underlying mechanism(s) were investigated." | 3.81 | Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice. ( Chang, KC, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nomura, K | 1 |
Miyashita, T | 1 |
Yamamoto, Y | 1 |
Munesue, S | 1 |
Harashima, A | 1 |
Takayama, H | 1 |
Fushida, S | 1 |
Ohta, T | 1 |
Chang, KC | 1 |
2 other studies available for cilostazol and Blood Poisoning
Article | Year |
---|---|
Citrullinated Histone H3: Early Biomarker of Neutrophil Extracellular Traps in Septic Liver Damage.
Topics: Animals; Biomarkers; Cilostazol; Citrullination; Extracellular Traps; Histones; Lipopolysaccharides; | 2019 |
Cilostazol inhibits HMGB1 release in LPS-activated RAW 264.7 cells and increases the survival of septic mice.
Topics: Animals; Anticoagulants; Cilostazol; Dose-Response Relationship, Drug; Heme Oxygenase-1; HMGB1 Prote | 2015 |